Two directors not standing for re-election at bioAffinity Technologies' 2026 annual meeting

bioAffinity Technologies, Inc.

Robert Anderson and Roby Joyce informed the board on March 5, 2026 of their decisions not to stand for re-election.
Their terms expire at the Annual Meeting currently scheduled for April 30, 2026.
The decisions did not result from any disagreements with the company on operations, policies, or practices.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.